These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 21390033)

  • 1. Beyond natural antibodies: the power of in vitro display technologies.
    Bradbury AR; Sidhu S; Dübel S; McCafferty J
    Nat Biotechnol; 2011 Mar; 29(3):245-54. PubMed ID: 21390033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies.
    Yau KY; Lee H; Hall JC
    Biotechnol Adv; 2003 Oct; 21(7):599-637. PubMed ID: 14516873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies and in vitro selection technologies.
    Geyer CR; McCafferty J; Dübel S; Bradbury AR; Sidhu SS
    Methods Mol Biol; 2012; 901():11-32. PubMed ID: 22723092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies: technologies for early discovery and engineering.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phage display in therapeutic antibody discovery.
    Chan CE; Lim AP; MacAry PA; Hanson BJ
    Int Immunol; 2014 Dec; 26(12):649-57. PubMed ID: 25135889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody phage display: overview of a powerful technology that has quickly translated to the clinic.
    Kotlan B; Glassy MC
    Methods Mol Biol; 2009; 562():1-15. PubMed ID: 19554283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage display and other peptide display technologies.
    Jaroszewicz W; Morcinek-Orłowska J; Pierzynowska K; Gaffke L; Węgrzyn G
    FEMS Microbiol Rev; 2022 Mar; 46(2):. PubMed ID: 34673942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Antibody Selections by Combining Phage and Yeast Display.
    Ferrara F; Soluri MF; Sblattero D
    Methods Mol Biol; 2019; 1904():339-352. PubMed ID: 30539479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic antibodies and other proteins obtained by molecular display technologies.
    Shibasaki S; Ueda M
    Recent Pat Biotechnol; 2009; 3(1):19-27. PubMed ID: 19149719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues.
    Kaleli NE; Karadag M; Kalyoncu S
    Proteins; 2019 Jul; 87(7):607-618. PubMed ID: 30883916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage display and colony filter screening for high-throughput selection of antibody libraries.
    Pini A; Ricci C; Bracci L
    Comb Chem High Throughput Screen; 2002 Nov; 5(7):503-10. PubMed ID: 12470263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural and designer binding sites made by phage display technology.
    Hoogenboom HR; Chames P
    Immunol Today; 2000 Aug; 21(8):371-8. PubMed ID: 10916139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of phage libraries for the in vitro production of recombinant monoclonal antibodies of predetermined specificity].
    Flego M; Ascione A; Pini A; Mennella V; Dupuis ML; Benagiano G; Cianfriglia M
    Ann Ist Super Sanita; 2002; 38(4):401-10. PubMed ID: 12760337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage display for the production of human monoclonal antibodies against human pathogens.
    Mancini N; Carletti S; Perotti M; Canducci F; Mammarella M; Sampaolo M; Burioni R
    New Microbiol; 2004 Oct; 27(4):315-28. PubMed ID: 15646045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage.
    Bowley DR; Labrijn AF; Zwick MB; Burton DR
    Protein Eng Des Sel; 2007 Feb; 20(2):81-90. PubMed ID: 17242026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation.
    Lim CC; Choong YS; Lim TS
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody phage display technology and its applications.
    Hoogenboom HR; de Bruïne AP; Hufton SE; Hoet RM; Arends JW; Roovers RC
    Immunotechnology; 1998 Jun; 4(1):1-20. PubMed ID: 9661810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage display-derived human antibodies in clinical development and therapy.
    Frenzel A; Schirrmann T; Hust M
    MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal construction of non-immune scFv phage display libraries from mouse bone marrow and spleen established to select specific scFvs efficiently binding to antigen.
    Okamoto T; Mukai Y; Yoshioka Y; Shibata H; Kawamura M; Yamamoto Y; Nakagawa S; Kamada H; Hayakawa T; Mayumi T; Tsutsumi Y
    Biochem Biophys Res Commun; 2004 Oct; 323(2):583-91. PubMed ID: 15369791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.